1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow James Larner, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HDCRT Plus Pembrolizumab in Advanced Malignancies High-Dose Conformal Radiation Therapy, Pembrolizumab - Solid Tumor | Phase 1 | Completed | James Larner, MD | 21 | 2017-03-21 | 2026-06-15 |
| Pilot Study of SBRT and CDX-1127 in Prostate Cancer CDX1127, SBRT - Prostatic Neoplasms, Prostate Cancer | Phase 1 | Terminated | James Larner, MD | 2 | 2014-11-01 | 2018-05-17 |
pembrolizumab (1) · varlilumab (1)
United States (2)